| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $31.7M | — | +324.9% |
| R&D Expense | $104.5M | — | +5.8% |
| SG&A Expense | $34.4M | — | +23.2% |
| Operating Income | -$107.2M | — | +10.1% |
| Income Tax | $0 | — | — |
| Net Income | -$94.3M | — | +13.7% |
| EPS (Basic) | -$0.91 | — | +26.6% |
| EPS (Diluted) | -$0.91 | — | +26.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $288.3M | -2.3% | -45.4% |
| Short-term Investments | $923.4M | -2.8% | +33.4% |
| Current Assets | $1.27B | -0.1% | +1.6% |
| Total Assets | $1.48B | -0.0% | +0.9% |
| Current Liabilities | $74.6M | -23.1% | -47.3% |
| Long-term Debt | $100.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$128.5M | — | -23.7% |
| Capital Expenditures | $2.2M | — | -27.2% |
| Investing Cash Flow | $25.3M | — | +120.2% |
| Financing Cash Flow | $96.6M | — | -79.6% |
| Free Cash Flow | -$130.7M | — | -22.2% |
| — |
| Total Liabilities | $316.4M | +30.3% | -8.0% |
| Stockholders' Equity | $1.16B | -6.0% | +3.7% |